SBIR/STTR Research Award
A Global Test of Hemostatic Risk
Award amount
$99,039Program and phase
SBIR · Phase IAward year
2004Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Haematologic Technologies, LLC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- NBRNPENP8AG9
- Solicitation number
- PHS2004-2
- Topic code
- Not reported
Research abstract
DESCRIPTION (provided by applicant): Although the vast majority of patients who suffer from venous or arterial thrombosis have haemostatic systems that fall within the "normal" range of routine screening tools such as PT, aPTT, and factor assays, throm
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Development of an Enhanced, Simplified Blood Coagulation Test to Monitor Patients on Direct Oral Anti-Coagulants
- A Global Test of Hemostatic Risk
- Fluorogenic Assays for Factor Vlla and Tissue Factor
- Murine Reagents and Analytical Tools
- Murine Reagents and Analytical Tools
Research funding history
12 SBIR/STTR records share this UEI (1989–2018). Reported award amounts total $2,518,708. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services